发明名称 |
Allogeneic cellular immunotherapy for opportunistic infection |
摘要 |
A method for stimulating the immune system in immunocompromised patients in order to treat opportunistic infection. The method involves the infusion of intentionally mismatched allogeneic cells. In order to prevent graft vs. host disease complications, the allogeneic cells can be irradiated prior to infusion. |
申请公布号 |
US2015024006(A1) |
申请公布日期 |
2015.01.22 |
申请号 |
US201414500395 |
申请日期 |
2014.09.29 |
申请人 |
Immunovative Therapies, Ltd. |
发明人 |
Har-Noy Michael |
分类号 |
A61K39/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of generating a de-novo Th1 anti-pathogen immunity in a host comprising:
inducing expression of Th1 cytokines; maintaining the Th1 cytokine environment during the activation of innate immune effector cells and until establishment of an anti-pathogen Th1 adaptive immune response wherein the host has a Th2-biased immunity. |
地址 |
Jerusalem IL |